Lantern Pharma Inc. (LTRN) IPO - S-1 Filing, Stock & Insider Activity
Lantern Pharma Inc. IPO - Status & S-1 Filing
- Ticker: LTRN
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2026-06-12
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- SEC CIK: 0001763950 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Lantern Pharma Inc. (LTRN) has filed 2 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-14. Insiders disclosed 4 open-market purchases totaling $200K. 4 Form 8-K material event filings were reported by LTRN in the last 90 days. InsiderAlpha tracks every LTRN SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. trades under the ticker LTRN. InsiderAlpha tracks 16 primary SEC Form 4 filings from 8 reporting insiders for LTRN since 2025, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001763950 |
90-Day SEC Filing Activity
| Insider purchases (90d) | 4 ($200K) |
|---|---|
| Form 4 filings (90d) | 2 |
| Form 8-K filings (90d) | 4 |
| Latest Form 4 filing | 2026-05-14 |
Recent LTRN Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lee Troy Schalop | Director | P - Open-market purchase | 48.5K | $2.06 | $100K | SEC | |
| D. Jeffrey Keyser | Director | P - Open-market purchase | 48.5K | $2.06 | $100K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Lantern Pharma Inc. (LTRN). Updated in real time as new filings are submitted to the SEC.
Most-Active LTRN Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| D. Jeffrey Keyser | 2 | $100K |
| Lee Troy Schalop | 2 | $100K |
Recent LTRN Form 8-K Material Events
- - Item 7.01, 9.01 [SEC]
- - Item 7.01, 9.01 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 1.01, 3.02, 8.01, 9.01 [SEC]
- - Item 7.01, 9.01 · Other · neutral [SEC]
Lantern Pharma held a live demonstration on April 9, 2026, showcasing withZeta.ai, its multi-agentic AI co-scientist platform for rare cancer drug discovery and clinical trial design. The presentation covered the platform's capabilities, commercial architecture, market opportunit
Recent Insider Filings
- - Lee Troy Schalop (Director)
- - D. Jeffrey Keyser (Director)
- - D. Jeffrey Keyser (Director)
- - Maria-Luisa Maccecchini (Director)
- - Vijay Chandru (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in LTRN insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
LTRN Insider Trading - FAQ
- What is the latest insider trade for LTRN?
- Lantern Pharma Inc. (LTRN) had 2 insider filings in the last 90 days, with the most recent on 2026-05-14. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying LTRN stock?
- 4 insider purchases of LTRN were filed in the last 90 days, totaling $200K.
- How many insiders are selling LTRN stock?
- 0 insider sales of LTRN were filed in the last 90 days.
- Where can I see LTRN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks LTRN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $LYEL Lyell Immunopharma, Inc.
- $MBX MBX Biosciences, Inc.
- $MDCX Medicus Pharma Ltd.
- $MDGL MADRIGAL PHARMACEUTICALS, INC.
- $MGRX MANGOCEUTICALS, INC.
- $MLYS Mineralys Therapeutics, Inc.
- $MODD Modular Medical, Inc.
- $MRUS Merus N.V.
- $MTVA MetaVia Inc.
- $NAMS NewAmsterdam Pharma Co N.V.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live LTRN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.